Praxis Precision Medicines Inc - PRAX Price Chart

Brandmark of Praxis Corp (PRAX)

Praxis Precision Medicines (PRAX) possesses exclusive pricing power in neurology due to the low demand elasticity for targeted therapies. This chart reflects a market valuation of 328.08. The company develops precision molecules to correct genetic brain malfunctions that are unresponsive to conventional methods. A high-intensity R&D pipeline focuses on developing breakthrough treatments for tremors and hereditary forms of epilepsy.

PRAX - praxismedicines.com Stock Price over the range 07/04/2022 - 11/15/2026

Praxis Medicines (PRAX) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Analysis of all company metrics:praxismedicines.com PRAX
Signature product of Praxis Precision Medicines Inc

The linear price action reflects the market status of Praxis Precision Medicines (PRAX) as an innovator in epilepsy therapy. The current value of 328.08 captures the asset's exchange value, adjusted for the latest financial results. Quotes measure the speed of capital reaction to revenue and profit data. The increase in this indicator confirms the high value of patents and protection against competitors. Such volatility underscores the company's potential for dominance within its sector.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|AVXL - Price Chart|Price Performance Chart CBLL (CeriBell EEG)|Prothena Corporation (PRTA) - Price Chart|Market Price Alector Inc. (ALEC)|ANNX (annexonbio.com) - Stock Price|Market Price omeros.com OMER|Stock Price NGNE|Stock Quotes AC Immune ACIU|Voyager Therapeutics Inc - Stock Quotes|Stock Price neumoratx.com NMRA|SCLX - Price Chart|Market Price Tevogen Bio|ACOG: Stock Price|CGTX - Market Chart|Price Chart Inhibikase Pharma|Price Chart SAVA|Stock Price ASRT|COYA (Coya Therapeutics) - Price Performance Chart|Price Chart vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Market Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel